Melbourne Brain Centre

Heidelberg, Victoria 3084

0 studies enrolling now · 2 studies all time

What they study most

Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Studies at this site

• Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) — Completed
• Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS) — Stopped early